HCA Healthcare, Inc. (NYSE: HCA – GET RATINGS) – The equities analysts at SVB Leerink published HCA Healthcare’s second-quarter 2022 earnings per share in a research report released for clients and investors on Friday, July 15. shortened. . SVB Leerink analyst W. Mayo now estimates that the company will earn $3.55 per share for the quarter, compared to its previous estimate of $3.81. SVB Leerink currently has an Outperform rating and a price target of $212.00 on the stock. The consensus estimate for HCA Healthcare’s current full-year earnings is $16.57 per share. SVB Leerink released estimates for HCA Healthcare’s fourth quarter 2022 earnings of $5.05 per share, Q1 2023 of $4.05 per share and Q3 2023 of $3.93 per share.
HCA Healthcare (NYSE: HCA – GET RATINGS) last released its quarterly results on Friday, April. The company reported earnings per share (EPS) of $4.12 for the quarter, falling short of analysts’ consensus estimate of $4.27 ($0.15). The company’s revenue for the quarter was $14.95 billion compared to the consensus estimate of $14.72 billion. HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The company’s quarterly revenue increased 6.9% compared to the same quarter last year. In the same quarter last year, the company posted earnings of $4.14 per share.
Other analysts have also published research reports on the company. UBS Group lowered its price target on HCA Healthcare to $241.00 from $289.00 and gave the stock a “buy” rating in a research note dated Tuesday, April 26. The Street upgraded HCA Healthcare from a “C+” rating to a “B-”. Rating in a research note on Monday, March 21. Wells Fargo & Co. lowered its price target on HCA Healthcare from $267. Oppenheimer published a research note on Monday, June 20th with a price target of $255.00 on HCA healthcare firm. Finally, Cowen lowered his price target on HCA Healthcare from $265.00 to $241.00 in a research note on Monday, April 25th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. According to Marketbeat, HCA Healthcare currently has a consensus rating of moderate buy and an average target price of $241.24.
HCA Healthcare stock up 2.5%
HCA shares opened at $171.61 on Monday. The company has a market cap of $50.71 billion, a PE ratio of 8.08, a P/E/G ratio of 1.20 and a beta of 1.65. The 50-day moving average of trading is $191.96 and the 200-day moving average is $228.46. HCA Healthcare’s 52-week low is $164.47 and its 52-week high is $279.02. The company’s quick ratio is 1.24, its current ratio is 1.43 and its debt to equity ratio is 87.46.
Hedge funds rate HCA Healthcare
Many institutional investors and hedge funds have recently added to or reduced their stock holdings. Equitec Proprietary Markets LLC acquired a new position in HCA Healthcare stock during the fourth quarter, valued at $26,000. Baltimore Washington Financial Advisors Inc initiated a new position in HCA Healthcare stock during the fourth quarter, valued at $26,000. GolWest Advisory LLC initiated a new position in shares of HCA Healthcare valued at $26,000 during the first quarter. Amplius Wealth Advisors LLC added a new position to shares of HCA Healthcare valued at $27,000 during the fourth quarter. Finally, Wolff Wisse Magana LLC increased its stake in HCA Healthcare shares by 1,833.3% during the first quarter. After purchasing an additional 110 shares in the previous quarter, Wolff Wisse Magana LLC now owns 116 shares of the company, valued at $29,000. Institutional investors and hedge funds own 67.87% of the company’s shares.
Insider activity at HCA Healthcare
In related news, Director Andrea B. Smith acquired 1,160 shares of HCA Healthcare in a transaction that took place on Thursday, April 28th. The stock was purchased at an average price of $213.63 per share for a total transaction of $247,810.80. Upon completion of the transaction, the Director now owns 2,239 shares of the Company, valued at $478,317.57. The acquisition was disclosed in a filing with the Securities and Exchange Commission, which is available on the SEC’s website. In related news, major shareholder Thomas F. Frist, Jr. acquired 89,100 shares of the stock in a transaction on Monday, May 2. Shares were purchased at an average price of $211.93 per share for a total value of $18,882,963.00. Upon completion of the purchase, the insider now owns 478,955 shares of the company’s stock, valued at approximately $101,504,933.15. The acquisition was disclosed in a filing with the Securities and Exchange Commission, available through the SEC’s website. In addition, on Thursday, April 28, Director Andrea B. Smith acquired 1,160 shares of the stock in a transaction. Shares were purchased at an average price of $213.63 per share for a total transaction of $247,810.80. Following the purchase, the director now directly owns 2,239 shares of the company, valued at approximately $478,317.57. The disclosure of this purchase can be found here. Over the past ninety days, insiders have bought 91,370 shares of the company’s stock, valued at $19,373,375. 1.50% of the shares are owned by company insiders.
HCA Healthcare Dividend Announcement
The company recently announced a quarterly dividend, which was paid on Thursday, June 30th. A dividend of $0.56 per share was paid to investors of record on Thursday, June 16. That equates to an annual dividend of $2.24 and a yield of 1.31%. The ex-dividend date was Wednesday June 15th. HCA Healthcare’s payout ratio currently stands at 10.54%.
About HCA Healthcare
(received rating)
HCA Healthcare, Inc., through its subsidiaries, provides healthcare services businesses in the United States. The Company operates general and acute care hospitals that provide medical and surgical services, including inpatient, critical care, cardiovascular, diagnostic and emergency services; and outpatient services such as outpatient surgery, laboratory, radiology, respiratory medicine, cardiology, and physical therapy.
Continue reading
Receive news and reviews for HCA Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for HCA Healthcare and related companies with Marketbeat.com’s FREE daily email newsletter.
source
